Ann: Corporate Update and Investor Presentation - Q1 2019, page-9

This company has left a trail of pissed off investors who bought in above 10c, not to mention those who were in CBIO upwards of multiple dollars. A lot of people are well down on their stake and just want to break even. The repurposed drugs that have been spun of into CAT showed good promise with smoking related problems but big pharma were not keen. They might have more luck in China, where respitory problems are rife and the government are keen to do something.
The company has been pretty quick on their feet but there is a feeling that Photosoft is the last roll of the dice and it is an Asian miracle that does seem to have something beyond a cult cure. On the slim chance that the phase 3 trials are successful there is still a chance they could do OK. I think that is what those that are still here are hoping. Going on road show has an air of desperation with more dilution the only way forward. GLTA We are going to need it.